Pinealon
Research OnlyEarly EvidencePinealon (Glu-Asp-Arg)
A pineal gland-derived tripeptide bioregulator from the Khavinson group, researched for neuroprotection, circadian rhythm support, and cognitive aging.
A three-amino-acid peptide from the pineal gland, studied by Russian researchers for neuroprotection and slowing cognitive decline with aging. Part of the Khavinson group's class of organ-specific short peptide bioregulators, which target specific tissues to restore age-related gene expression changes.
Half-Life
Not well characterized
Molecular Weight
417.4 g/mol
Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology — the same group behind Epithalon and Cartalax. While Epithalon was derived from the pineal peptide fraction Epiphamine, Pinealon was developed specifically as a neuroprotective peptide bioregulator. Preclinical research suggests it may penetrate the blood-brain barrier and exert neuroprotective effects in oxidative stress and hypoxia models. Studies from the Khavinson group report benefits in cognitive aging, hypoxic brain injury models, and circadian rhythm-related decline. Like other Khavinson bioregulators, the evidence base is almost entirely from the originating research group and has not been independently replicated.
Also Known As
Amino Acid Sequence
Glu-Asp-Arg
Reconstitution
Reconstitute with bacteriostatic water. Store refrigerated. Use within 30 days.
Open Reconstitution Calculator →